InvestorsHub Logo
Followers 134
Posts 3737
Boards Moderated 0
Alias Born 01/28/2006

Re: KMBJN post# 376601

Thursday, 09/30/2021 12:24:20 AM

Thursday, September 30, 2021 12:24:20 AM

Post# of 402731
I agree.

"It could easily be interpreted to say that this thing (pandemic / virus) will go through society at its own pace, infecting both the vaccinated and unvaccinated the same way
initially (though lower chance of being infected if vaccinated). I do believe vaccination will save people from severe disease, but that's about all one can say for SARS2-delta infection, at least based on this study. Would like to see more data on SARS2-delta hospitalizations and severe disease based on vaccination status.

Some experts, including UK's Oxford Vaccine Group, have stated the only end to the pandemic and achieve herd immunity will be when the unvaccinated and vaccinated have been infected and achieve "natural immunity"

https://www.theguardian.com/world/2021/aug/10/delta-variant-renders-herd-immunity-from-covid-mythical

Others question the wisdom of vaccinating children.

https://khn.org/news/article/covid-vaccination-children-rare-side-effects-myocarditis-experts-caution/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437699/

I agree there is little US data on delta complications and vaccine complications. The best data has come from the UK and Israel.

Unfortunately the vaccines do not work as well as we had hoped against the delta variant. As long as the vaccinated can catch covid 19 and spread it there is little hope for herd immunity. It is clear vaccination is a benefit to the elderly and high risk individuals. It is less clear what benefit will come from vaccinating healthy children and young adults.

With those observations developing therapeutics should be a high priority.

Hopefully Brilacidin will prove useful against covid19.

GLTA,

Farrell

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News